Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rothenberg

Showing results (591-600 of 658) with videos related to

Pageof 66
Sort By:
Science Translational Medicine|February 23, 2018
Eosinophil depletion suppresses radiation-induced small intestinal fibrosisNaoki Takemura, Yosuke Kurashima, Yuki Mori, et al.
Gastroenterology|October 9, 2019
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic EsophagitisIkuo Hirano, Evan S Dellon, Jennifer D Hamilton, et al.
Gastroenterology|November 6, 2018
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic EsophagitisIkuo Hirano, Margaret H Collins, Yehudith Assouline-Dayan, et al.
Nature Biotechnology|November 15, 2011
Single-cell dissection of transcriptional heterogeneity in human colon tumorsPiero Dalerba, Tomer Kalisky, Debashis Sahoo, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2009
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapyPrincess U Ogbogu, Bruce S Bochner, Joseph H Butterfield, et al.
The Lancet. Gastroenterology & Hepatology|June 19, 2023
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trialKara L Kliewer, Cristin Murray-Petzold, Margaret H Collins, et al.
Nature Communications|November 25, 2025
Epigenetic and transcriptional programming of murine eosinophils in the esophagusJennifer M Felton, Lee E Edsall, Ty D Troutman, et al.
Nature Communications|November 24, 2021
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitisTetsuo Shoda, Kenneth M Kaufman, Ting Wen, et al.
The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.
The American Journal of Gastroenterology|April 23, 2019
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter ConsortiumRobert D Pesek, Craig C Reed, Amanda B Muir, et al.
Pageof 66

Showing results (591-600 of 658) with videos related to

Sort By:
Pageof 66
Science Translational Medicine|February 23, 2018
Eosinophil depletion suppresses radiation-induced small intestinal fibrosisNaoki Takemura, Yosuke Kurashima, Yuki Mori, et al.
Gastroenterology|October 9, 2019
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic EsophagitisIkuo Hirano, Evan S Dellon, Jennifer D Hamilton, et al.
Gastroenterology|November 6, 2018
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic EsophagitisIkuo Hirano, Margaret H Collins, Yehudith Assouline-Dayan, et al.
Nature Biotechnology|November 15, 2011
Single-cell dissection of transcriptional heterogeneity in human colon tumorsPiero Dalerba, Tomer Kalisky, Debashis Sahoo, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2009
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapyPrincess U Ogbogu, Bruce S Bochner, Joseph H Butterfield, et al.
The Lancet. Gastroenterology & Hepatology|June 19, 2023
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trialKara L Kliewer, Cristin Murray-Petzold, Margaret H Collins, et al.
Nature Communications|November 25, 2025
Epigenetic and transcriptional programming of murine eosinophils in the esophagusJennifer M Felton, Lee E Edsall, Ty D Troutman, et al.
Nature Communications|November 24, 2021
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitisTetsuo Shoda, Kenneth M Kaufman, Ting Wen, et al.
The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.
The American Journal of Gastroenterology|April 23, 2019
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter ConsortiumRobert D Pesek, Craig C Reed, Amanda B Muir, et al.
Pageof 66